
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Meta-Analysis of Postoperative Adjuvant Hepatic Artery Infusion Chemotherapy Versus Surgical Resection Alone for Hepatocellular Carcinoma
Qiao Ke, Lei Wang, Weimin Wu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Qiao Ke, Lei Wang, Weimin Wu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Showing 14 citing articles:
Advances in the surgical treatment of liver cancer
Harufumi Maki, Kiyoshi Hasegawa
BioScience Trends (2022) Vol. 16, Iss. 3, pp. 178-188
Open Access | Times Cited: 76
Harufumi Maki, Kiyoshi Hasegawa
BioScience Trends (2022) Vol. 16, Iss. 3, pp. 178-188
Open Access | Times Cited: 76
Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
Li Jiang, Fan Yang, Jian Li, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 1, pp. 19-31
Open Access | Times Cited: 11
Li Jiang, Fan Yang, Jian Li, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 1, pp. 19-31
Open Access | Times Cited: 11
Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
Bin Guo, Qian Chen, Zhicheng Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Bin Guo, Qian Chen, Zhicheng Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis
Lingbo Hu, Yu Zheng, Jiangyin Lin, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Lingbo Hu, Yu Zheng, Jiangyin Lin, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma
Feng Xu, Guoying Feng, Jie Tao, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 12, pp. 10505-10518
Closed Access | Times Cited: 7
Feng Xu, Guoying Feng, Jie Tao, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 12, pp. 10505-10518
Closed Access | Times Cited: 7
Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition)
Xiufeng Liu, Feng Xia, Yue Chen, et al.
Liver Research (2024) Vol. 8, Iss. 2, pp. 61-71
Open Access | Times Cited: 2
Xiufeng Liu, Feng Xia, Yue Chen, et al.
Liver Research (2024) Vol. 8, Iss. 2, pp. 61-71
Open Access | Times Cited: 2
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma.
Bernardo Stefanini, Giulia Francesca Manfredi, Antonio D’Alessio, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 10, pp. 647-660
Open Access | Times Cited: 2
Bernardo Stefanini, Giulia Francesca Manfredi, Antonio D’Alessio, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 10, pp. 647-660
Open Access | Times Cited: 2
Consensus on the tertiary prevention of primary liver cancer
Yuemin Nan, Xiaoyuan Xu, Shiming Dong, et al.
Hepatology International (2023) Vol. 17, Iss. 5, pp. 1057-1071
Open Access | Times Cited: 6
Yuemin Nan, Xiaoyuan Xu, Shiming Dong, et al.
Hepatology International (2023) Vol. 17, Iss. 5, pp. 1057-1071
Open Access | Times Cited: 6
Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection
Yanyan Ye, Ying Wang, Haoqian Xu, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Yanyan Ye, Ying Wang, Haoqian Xu, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Comparative effectiveness of several adjuvant therapies after hepatectomy for hepatocellular carcinoma patients with microvascular invasion
Yinxuan Pei, Chen-Guang Su, Zheng Liao, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 2, pp. 554-570
Open Access | Times Cited: 1
Yinxuan Pei, Chen-Guang Su, Zheng Liao, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 2, pp. 554-570
Open Access | Times Cited: 1
Inverse Probability of Treatment Weighting in 5-Year Quality-of-Life Comparison among Three Surgical Procedures for Hepatocellular Carcinoma
Der‐Ming Chang, Yu-Fu Chen, Hong-Yaw Chen, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 252-252
Open Access | Times Cited: 5
Der‐Ming Chang, Yu-Fu Chen, Hong-Yaw Chen, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 252-252
Open Access | Times Cited: 5
Revolutionizing hepatocellular carcinoma treatment: the advent of a new era of adjuvant therapy
Joshua Sheng Hao Lim, Vishal G. Shelat
Chinese Clinical Oncology (2023) Vol. 12, Iss. 5, pp. 49-49
Open Access | Times Cited: 2
Joshua Sheng Hao Lim, Vishal G. Shelat
Chinese Clinical Oncology (2023) Vol. 12, Iss. 5, pp. 49-49
Open Access | Times Cited: 2
Insights in Molecular Therapies for Hepatocellular Carcinoma
Philipp Heumann, Andreas Albert, Karsten Gülow, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1831-1831
Open Access
Philipp Heumann, Andreas Albert, Karsten Gülow, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1831-1831
Open Access
A contemporary view on vascular resections and reconstruction during hepatectomies
Luca Tirloni, Ilenia Bartolini, Carlo Gazia, et al.
Updates in Surgery (2024) Vol. 76, Iss. 5, pp. 1643-1653
Closed Access
Luca Tirloni, Ilenia Bartolini, Carlo Gazia, et al.
Updates in Surgery (2024) Vol. 76, Iss. 5, pp. 1643-1653
Closed Access